newsfilter
← Latest News
Business Wire·

Quince Therapeutics to Participate at A-T Society's 2025 A-T Clinical Research Conference

Phase 3 NEAT enrollment momentum continues with 99 total participants enrolled to date Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own